Global Antidiabetics Sales Market Report 2017

January 2017 | 114 pages | ID: GD523A3037DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antidiabetics

Revenue, means the sales value of Antidiabetics

This report studies sales (consumption) of Antidiabetics in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Novo Nordisk
• Sanofi
• Eli Lilly
• GlaxoSmithKline
• Merck
• MannKind
• Takeda
• Johnson & Johnson
• AstraZeneca
• Bristol-Myers Squibb
• Boehringer Ingelheim
• Novartis
• BIOTON
• Salix Pharmaceuticals
• AstraZeneca

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antidiabetics in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Rapid Acting
• Long Acting
• Short Acting
• Others

Split by applications, this report focuses on sales, market share and growth rate of Antidiabetics in each application, can be divided into

• Hospital
• Clinic

Contents

Global Antidiabetics Sales Market Report 2017

1 ANTIDIABETICS OVERVIEW

1.1 Product Overview and Scope of Antidiabetics
1.2 Classification of Antidiabetics
  1.2.1 Rapid Acting
  1.2.2 Long Acting
  1.2.3 Short Acting
  1.2.4 Others
1.3 Application of Antidiabetics
  1.3.1 Hospital
  1.3.2 Clinic
1.4 Antidiabetics Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Antidiabetics (2011-2021)
  1.5.1 Global Antidiabetics Sales and Growth Rate (2011-2021)
  1.5.2 Global Antidiabetics Revenue and Growth Rate (2011-2021)

2 GLOBAL ANTIDIABETICS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Antidiabetics Market Competition by Manufacturers
  2.1.1 Global Antidiabetics Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Antidiabetics Revenue and Share by Manufacturers (2011-2016)
2.2 Global Antidiabetics (Volume and Value) by Type
  2.2.1 Global Antidiabetics Sales and Market Share by Type (2011-2016)
  2.2.2 Global Antidiabetics Revenue and Market Share by Type (2011-2016)
2.3 Global Antidiabetics (Volume and Value) by Regions
  2.3.1 Global Antidiabetics Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Antidiabetics Revenue and Market Share by Regions (2011-2016)
2.4 Global Antidiabetics (Volume) by Application

3 UNITED STATES ANTIDIABETICS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Antidiabetics Sales and Value (2011-2016)
  3.1.1 United States Antidiabetics Sales and Growth Rate (2011-2016)
  3.1.2 United States Antidiabetics Revenue and Growth Rate (2011-2016)
  3.1.3 United States Antidiabetics Sales Price Trend (2011-2016)
3.2 United States Antidiabetics Sales and Market Share by Manufacturers
3.3 United States Antidiabetics Sales and Market Share by Type
3.4 United States Antidiabetics Sales and Market Share by Application

4 CHINA ANTIDIABETICS (VOLUME, VALUE AND SALES PRICE)

4.1 China Antidiabetics Sales and Value (2011-2016)
  4.1.1 China Antidiabetics Sales and Growth Rate (2011-2016)
  4.1.2 China Antidiabetics Revenue and Growth Rate (2011-2016)
  4.1.3 China Antidiabetics Sales Price Trend (2011-2016)
4.2 China Antidiabetics Sales and Market Share by Manufacturers
4.3 China Antidiabetics Sales and Market Share by Type
4.4 China Antidiabetics Sales and Market Share by Application

5 EUROPE ANTIDIABETICS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Antidiabetics Sales and Value (2011-2016)
  5.1.1 Europe Antidiabetics Sales and Growth Rate (2011-2016)
  5.1.2 Europe Antidiabetics Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Antidiabetics Sales Price Trend (2011-2016)
5.2 Europe Antidiabetics Sales and Market Share by Manufacturers
5.3 Europe Antidiabetics Sales and Market Share by Type
5.4 Europe Antidiabetics Sales and Market Share by Application

6 JAPAN ANTIDIABETICS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Antidiabetics Sales and Value (2011-2016)
  6.1.1 Japan Antidiabetics Sales and Growth Rate (2011-2016)
  6.1.2 Japan Antidiabetics Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Antidiabetics Sales Price Trend (2011-2016)
6.2 Japan Antidiabetics Sales and Market Share by Manufacturers
6.3 Japan Antidiabetics Sales and Market Share by Type
6.4 Japan Antidiabetics Sales and Market Share by Application

7 SOUTHEAST ASIA ANTIDIABETICS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Antidiabetics Sales and Value (2011-2016)
  7.1.1 Southeast Asia Antidiabetics Sales and Growth Rate (2011-2016)
  7.1.2 Southeast Asia Antidiabetics Revenue and Growth Rate (2011-2016)
  7.1.3 Southeast Asia Antidiabetics Sales Price Trend (2011-2016)
7.2 Southeast Asia Antidiabetics Sales and Market Share by Manufacturers
7.3 Southeast Asia Antidiabetics Sales and Market Share by Type
7.4 Southeast Asia Antidiabetics Sales and Market Share by Application

8 INDIA ANTIDIABETICS (VOLUME, VALUE AND SALES PRICE)

8.1 India Antidiabetics Sales and Value (2011-2016)
  8.1.1 India Antidiabetics Sales and Growth Rate (2011-2016)
  8.1.2 India Antidiabetics Revenue and Growth Rate (2011-2016)
  8.1.3 India Antidiabetics Sales Price Trend (2011-2016)
8.2 India Antidiabetics Sales and Market Share by Manufacturers
8.3 India Antidiabetics Sales and Market Share by Type
8.4 India Antidiabetics Sales and Market Share by Application

9 GLOBAL ANTIDIABETICS MANUFACTURERS ANALYSIS

9.1 Novo Nordisk
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Antidiabetics Product Type, Application and Specification
    9.1.2.1 Rapid Acting
    9.1.2.2 Long Acting
  9.1.3 Novo Nordisk Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Sanofi
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Antidiabetics Product Type, Application and Specification
    9.2.2.1 Rapid Acting
    9.2.2.2 Long Acting
  9.2.3 Sanofi Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 Eli Lilly
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Antidiabetics Product Type, Application and Specification
    9.3.2.1 Rapid Acting
    9.3.2.2 Long Acting
  9.3.3 Eli Lilly Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Antidiabetics Product Type, Application and Specification
    9.4.2.1 Rapid Acting
    9.4.2.2 Long Acting
  9.4.3 GlaxoSmithKline Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 Merck
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Antidiabetics Product Type, Application and Specification
    9.5.2.1 Rapid Acting
    9.5.2.2 Long Acting
  9.5.3 Merck Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 MannKind
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Antidiabetics Product Type, Application and Specification
    9.6.2.1 Rapid Acting
    9.6.2.2 Long Acting
  9.6.3 MannKind Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Takeda
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Antidiabetics Product Type, Application and Specification
    9.7.2.1 Rapid Acting
    9.7.2.2 Long Acting
  9.7.3 Takeda Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 Johnson & Johnson
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Antidiabetics Product Type, Application and Specification
    9.8.2.1 Rapid Acting
    9.8.2.2 Long Acting
  9.8.3 Johnson & Johnson Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview
9.9 AstraZeneca
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Antidiabetics Product Type, Application and Specification
    9.9.2.1 Rapid Acting
    9.9.2.2 Long Acting
  9.9.3 AstraZeneca Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  9.9.4 Main Business/Business Overview
9.10 Bristol-Myers Squibb
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Antidiabetics Product Type, Application and Specification
    9.10.2.1 Rapid Acting
    9.10.2.2 Long Acting
  9.10.3 Bristol-Myers Squibb Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
  9.10.4 Main Business/Business Overview
9.11 Boehringer Ingelheim
9.12 Novartis
9.13 BIOTON
9.14 Salix Pharmaceuticals
9.15 AstraZeneca

10 ANTIDIABETICS MAUFACTURING COST ANALYSIS

10.1 Antidiabetics Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Antidiabetics
10.3 Manufacturing Process Analysis of Antidiabetics

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Antidiabetics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antidiabetics Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL ANTIDIABETICS MARKET FORECAST (2016-2021)

14.1 Global Antidiabetics Sales, Revenue and Price Forecast (2016-2021)
  14.1.1 Global Antidiabetics Sales and Growth Rate Forecast (2016-2021)
  14.1.2 Global Antidiabetics Revenue and Growth Rate Forecast (2016-2021)
  14.1.3 Global Antidiabetics Price and Trend Forecast (2016-2021)
14.2 Global Antidiabetics Sales, Revenue and Growth Rate Forecast by Regions (2016-2021)
  14.2.1 United States Antidiabetics Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.2 China Antidiabetics Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.3 Europe Antidiabetics Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.4 Japan Antidiabetics Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.5 Southeast Asia Antidiabetics Sales, Revenue and Growth Rate Forecast (2016-2021)
  14.2.6 India Antidiabetics Sales, Revenue and Growth Rate Forecast (2016-2021)
14.3 Global Antidiabetics Sales, Revenue and Price Forecast by Type (2016-2021)
14.4 Global Antidiabetics Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetics
Table Classification of Antidiabetics
Figure Global Sales Market Share of Antidiabetics by Type in 2015
Figure Rapid Acting Picture
Figure Long Acting Picture
Figure Short Acting Picture
Figure Others Picture
Table Applications of Antidiabetics
Figure Global Sales Market Share of Antidiabetics by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Antidiabetics Revenue and Growth Rate (2011-2021)
Figure China Antidiabetics Revenue and Growth Rate (2011-2021)
Figure Europe Antidiabetics Revenue and Growth Rate (2011-2021)
Figure Japan Antidiabetics Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Antidiabetics Revenue and Growth Rate (2011-2021)
Figure India Antidiabetics Revenue and Growth Rate (2011-2021)
Figure Global Antidiabetics Sales and Growth Rate (2011-2021)
Figure Global Antidiabetics Revenue and Growth Rate (2011-2021)
Table Global Antidiabetics Sales of Key Manufacturers (2011-2016)
Table Global Antidiabetics Sales Share by Manufacturers (2011-2016)
Figure 2015 Antidiabetics Sales Share by Manufacturers
Figure 2016 Antidiabetics Sales Share by Manufacturers
Table Global Antidiabetics Revenue by Manufacturers (2011-2016)
Table Global Antidiabetics Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Antidiabetics Revenue Share by Manufacturers
Table 2016 Global Antidiabetics Revenue Share by Manufacturers
Table Global Antidiabetics Sales and Market Share by Type (2011-2016)
Table Global Antidiabetics Sales Share by Type (2011-2016)
Figure Sales Market Share of Antidiabetics by Type (2011-2016)
Figure Global Antidiabetics Sales Growth Rate by Type (2011-2016)
Table Global Antidiabetics Revenue and Market Share by Type (2011-2016)
Table Global Antidiabetics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antidiabetics by Type (2011-2016)
Figure Global Antidiabetics Revenue Growth Rate by Type (2011-2016)
Table Global Antidiabetics Sales and Market Share by Regions (2011-2016)
Table Global Antidiabetics Sales Share by Regions (2011-2016)
Figure Sales Market Share of Antidiabetics by Regions (2011-2016)
Figure Global Antidiabetics Sales Growth Rate by Regions (2011-2016)
Table Global Antidiabetics Revenue and Market Share by Regions (2011-2016)
Table Global Antidiabetics Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Antidiabetics by Regions (2011-2016)
Figure Global Antidiabetics Revenue Growth Rate by Regions (2011-2016)
Table Global Antidiabetics Sales and Market Share by Application (2011-2016)
Table Global Antidiabetics Sales Share by Application (2011-2016)
Figure Sales Market Share of Antidiabetics by Application (2011-2016)
Figure Global Antidiabetics Sales Growth Rate by Application (2011-2016)
Figure United States Antidiabetics Sales and Growth Rate (2011-2016)
Figure United States Antidiabetics Revenue and Growth Rate (2011-2016)
Figure United States Antidiabetics Sales Price Trend (2011-2016)
Table United States Antidiabetics Sales by Manufacturers (2011-2016)
Table United States Antidiabetics Market Share by Manufacturers (2011-2016)
Table United States Antidiabetics Sales by Type (2011-2016)
Table United States Antidiabetics Market Share by Type (2011-2016)
Table United States Antidiabetics Sales by Application (2011-2016)
Table United States Antidiabetics Market Share by Application (2011-2016)
Figure China Antidiabetics Sales and Growth Rate (2011-2016)
Figure China Antidiabetics Revenue and Growth Rate (2011-2016)
Figure China Antidiabetics Sales Price Trend (2011-2016)
Table China Antidiabetics Sales by Manufacturers (2011-2016)
Table China Antidiabetics Market Share by Manufacturers (2011-2016)
Table China Antidiabetics Sales by Type (2011-2016)
Table China Antidiabetics Market Share by Type (2011-2016)
Table China Antidiabetics Sales by Application (2011-2016)
Table China Antidiabetics Market Share by Application (2011-2016)
Figure Europe Antidiabetics Sales and Growth Rate (2011-2016)
Figure Europe Antidiabetics Revenue and Growth Rate (2011-2016)
Figure Europe Antidiabetics Sales Price Trend (2011-2016)
Table Europe Antidiabetics Sales by Manufacturers (2011-2016)
Table Europe Antidiabetics Market Share by Manufacturers (2011-2016)
Table Europe Antidiabetics Sales by Type (2011-2016)
Table Europe Antidiabetics Market Share by Type (2011-2016)
Table Europe Antidiabetics Sales by Application (2011-2016)
Table Europe Antidiabetics Market Share by Application (2011-2016)
Figure Japan Antidiabetics Sales and Growth Rate (2011-2016)
Figure Japan Antidiabetics Revenue and Growth Rate (2011-2016)
Figure Japan Antidiabetics Sales Price Trend (2011-2016)
Table Japan Antidiabetics Sales by Manufacturers (2011-2016)
Table Japan Antidiabetics Market Share by Manufacturers (2011-2016)
Table Japan Antidiabetics Sales by Type (2011-2016)
Table Japan Antidiabetics Market Share by Type (2011-2016)
Table Japan Antidiabetics Sales by Application (2011-2016)
Table Japan Antidiabetics Market Share by Application (2011-2016)
Figure Southeast Asia Antidiabetics Sales and Growth Rate (2011-2016)
Figure Southeast Asia Antidiabetics Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Antidiabetics Sales Price Trend (2011-2016)
Table Southeast Asia Antidiabetics Sales by Manufacturers (2011-2016)
Table Southeast Asia Antidiabetics Market Share by Manufacturers (2011-2016)
Table Southeast Asia Antidiabetics Sales by Type (2011-2016)
Table Southeast Asia Antidiabetics Market Share by Type (2011-2016)
Table Southeast Asia Antidiabetics Sales by Application (2011-2016)
Table Southeast Asia Antidiabetics Market Share by Application (2011-2016)
Figure India Antidiabetics Sales and Growth Rate (2011-2016)
Figure India Antidiabetics Revenue and Growth Rate (2011-2016)
Figure India Antidiabetics Sales Price Trend (2011-2016)
Table India Antidiabetics Sales by Manufacturers (2011-2016)
Table India Antidiabetics Market Share by Manufacturers (2011-2016)
Table India Antidiabetics Sales by Type (2011-2016)
Table India Antidiabetics Market Share by Type (2011-2016)
Table India Antidiabetics Sales by Application (2011-2016)
Table India Antidiabetics Market Share by Application (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Antidiabetics Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Antidiabetics Global Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Antidiabetics Global Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Antidiabetics Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Antidiabetics Global Market Share (2011-2016)
Table MannKind Basic Information List
Table MannKind Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MannKind Antidiabetics Global Market Share (2011-2016)
Table Takeda Basic Information List
Table Takeda Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Antidiabetics Global Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Antidiabetics Global Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Antidiabetics Global Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Antidiabetics Global Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Novartis Basic Information List
Table BIOTON Basic Information List
Table Salix Pharmaceuticals Basic Information List
Table AstraZeneca Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetics
Figure Manufacturing Process Analysis of Antidiabetics
Figure Antidiabetics Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetics Major Manufacturers in 2015
Table Major Buyers of Antidiabetics
Table Distributors/Traders List
Figure Global Antidiabetics Sales and Growth Rate Forecast (2016-2021)
Figure Global Antidiabetics Revenue and Growth Rate Forecast (2016-2021)
Table Global Antidiabetics Sales Forecast by Regions (2016-2021)
Table Global Antidiabetics Sales Forecast by Type (2016-2021)
Table Global Antidiabetics Sales Forecast by Application (2016-2021)